Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ikuo Sekine

Showing results (1-10 of 177) with videos related to

Pageof 18
Sort By:
Internal Medicine (Tokyo, Japan)|July 12, 2019
A Prompt Diagnosis of Superior Vena Cava Obstruction Established by Physical ExaminationIkuo Sekine
Journal of Thoracic Disease|January 10, 2017
Are there any differences in genomic characterization of non-small cell lung cancer between African Americans and Whites?Ikuo Sekine
Japanese Journal of Clinical Oncology|February 17, 2017
Case reports of adverse drug reactions associated with nivolumab administrationIkuo Sekine
Journal of Thoracic Disease|June 16, 2017
What is the optimal first-line treatment for advanced anaplastic lymphoma kinase-rearranged non-small cell lung cancer?Ikuo Sekine
Japanese Journal of Clinical Oncology|August 4, 2023
Clinical development of immune checkpoint inhibitors in Japan-the same goal, different pathsIkuo Sekine
Expert Review of Respiratory Medicine|May 19, 2010
Is there a need to take ethnicity into account when considering lung cancer treatment?Ikuo Sekine
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 3, 2014
Clinical characteristics and functional assessment of elderly patients with cancerIkuo Sekine
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 19, 2015
[Targeted therapy for solid tumors in the elderly]Hironori Ashinuma, Ikuo Sekine
Japanese Journal of Clinical Oncology|March 29, 2022
Atherosclerotic cardiovascular events associated with immune checkpoint inhibitors in cancer patientsKazuko Tajiri, Ikuo Sekine
The Tohoku Journal of Experimental Medicine|May 1, 2013
Clinical classification of targeted agents used for anticancer treatmentIkuo Sekine, Yuichi Takiguchi
Pageof 18

Showing results (1-10 of 177) with videos related to

Sort By:
Pageof 18
Internal Medicine (Tokyo, Japan)|July 12, 2019
A Prompt Diagnosis of Superior Vena Cava Obstruction Established by Physical ExaminationIkuo Sekine
Journal of Thoracic Disease|January 10, 2017
Are there any differences in genomic characterization of non-small cell lung cancer between African Americans and Whites?Ikuo Sekine
Japanese Journal of Clinical Oncology|February 17, 2017
Case reports of adverse drug reactions associated with nivolumab administrationIkuo Sekine
Journal of Thoracic Disease|June 16, 2017
What is the optimal first-line treatment for advanced anaplastic lymphoma kinase-rearranged non-small cell lung cancer?Ikuo Sekine
Japanese Journal of Clinical Oncology|August 4, 2023
Clinical development of immune checkpoint inhibitors in Japan-the same goal, different pathsIkuo Sekine
Expert Review of Respiratory Medicine|May 19, 2010
Is there a need to take ethnicity into account when considering lung cancer treatment?Ikuo Sekine
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 3, 2014
Clinical characteristics and functional assessment of elderly patients with cancerIkuo Sekine
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 19, 2015
[Targeted therapy for solid tumors in the elderly]Hironori Ashinuma, Ikuo Sekine
Japanese Journal of Clinical Oncology|March 29, 2022
Atherosclerotic cardiovascular events associated with immune checkpoint inhibitors in cancer patientsKazuko Tajiri, Ikuo Sekine
The Tohoku Journal of Experimental Medicine|May 1, 2013
Clinical classification of targeted agents used for anticancer treatmentIkuo Sekine, Yuichi Takiguchi
Pageof 18